Syngene International Ltd. ( (IN:SYNGENE) ) has shared an update.
Syngene International Limited has announced changes in its management team, with the appointment of Dr. Sanjaya Singh and Mr. Suresh Narayanan as Additional Directors, effective July 1, 2025, and August 1, 2025, respectively. These appointments are subject to shareholder approval and are part of the company’s strategic efforts to strengthen its board with experienced leadership. Additionally, the company announced the resignation of Ms. Priyadarshini Mahapatra, Head Legal, Company Secretary & Compliance Officer, effective June 9, 2025. These changes reflect Syngene’s commitment to enhancing its governance and operational capabilities.
More about Syngene International Ltd.
Syngene International Limited is a leading contract research and manufacturing organization in the biotechnology industry. The company provides integrated services in drug discovery, development, and manufacturing for pharmaceutical and biotechnology companies globally.
YTD Price Performance: -16.27%
Average Trading Volume: 46,039
Current Market Cap: 296B INR
For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.